Forest bets on growth with $2.9bn Aptalis buy
This article was originally published in Scrip
Executive Summary
With the $2.9bn acquisition of Aptalis, new Forest Laboratories CEO Brent Saunders is delivering deals in rapid succession to fulfill the company's strategy for growth.